BioCentury
ARTICLE | Clinical News

Sevuparin/DF02: Phase I/II started

October 10, 2011 7:00 AM UTC

Dilaforette began an open-label, dose-escalation, Thai Phase I/II trial to compare Malanil atovaquone/proguanil plus IV Sevuparin/DF02 vs. Malanil alone in about 98 patients with uncomplicated falcipa...